Clinical Trial Update: Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of stereotactic radiation and nivolumab for metastatic breast cancer with brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Breast Cancer, Brain Metastases | Phase 1 | Status: COMPLETED